Jin Takeuchi

2.7k total citations
94 papers, 1.7k citations indexed

About

Jin Takeuchi is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Jin Takeuchi has authored 94 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Hematology, 26 papers in Public Health, Environmental and Occupational Health and 22 papers in Genetics. Recurrent topics in Jin Takeuchi's work include Acute Myeloid Leukemia Research (34 papers), Acute Lymphoblastic Leukemia research (25 papers) and Chronic Myeloid Leukemia Treatments (24 papers). Jin Takeuchi is often cited by papers focused on Acute Myeloid Leukemia Research (34 papers), Acute Lymphoblastic Leukemia research (25 papers) and Chronic Myeloid Leukemia Treatments (24 papers). Jin Takeuchi collaborates with scholars based in Japan, United States and Norway. Jin Takeuchi's co-authors include Yoshihiro Hatta, Tomoki Naoe, Shuichi Miyawaki, Ryuzo Ohno, Shigeki Ohtake, Yasushi Miyazaki, Noriyoshi Iriyama, Noriko Usui, Akira Horikoshi and Avery A. Sandberg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Jin Takeuchi

90 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jin Takeuchi Japan	22	987	605	448	390	344	94	1.7k
Hiroaki Goto Japan	22	634 0.6×	476 0.8×	485 1.1×	364 0.9×	171 0.5×	157	1.7k
Fumio Bessho Japan	29	1.1k 1.2×	502 0.8×	863 1.9×	357 0.9×	286 0.8×	102	2.4k
Shuichi Miyawaki Japan	26	2.0k 2.1×	854 1.4×	864 1.9×	597 1.5×	641 1.9×	121	2.8k
Anna Porwit‐MacDonald Sweden	30	1.1k 1.2×	756 1.2×	610 1.4×	604 1.5×	631 1.8×	50	2.7k
DS Snyder United States	17	838 0.8×	334 0.6×	305 0.7×	368 0.9×	205 0.6×	29	1.5k
Yoshihiro Hatta Japan	23	654 0.7×	317 0.5×	828 1.8×	848 2.2×	367 1.1×	159	2.3k
Marcel P. Devetten United States	20	704 0.7×	216 0.4×	433 1.0×	263 0.7×	594 1.7×	45	1.5k
Marie‐Thérèse Daniel France	30	1.4k 1.4×	663 1.1×	1.2k 2.6×	818 2.1×	499 1.5×	58	2.8k
Miloslav Beran United States	26	1.5k 1.6×	347 0.6×	897 2.0×	483 1.2×	757 2.2×	81	2.5k
Robert Schoch Germany	12	1.7k 1.7×	352 0.6×	972 2.2×	282 0.7×	604 1.8×	21	2.3k

Countries citing papers authored by Jin Takeuchi

Since Specialization

Citations

This map shows the geographic impact of Jin Takeuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Takeuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Takeuchi more than expected).

Fields of papers citing papers by Jin Takeuchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Takeuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Takeuchi. The network helps show where Jin Takeuchi may publish in the future.

Co-authorship network of co-authors of Jin Takeuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Takeuchi. A scholar is included among the top collaborators of Jin Takeuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Takeuchi. Jin Takeuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakagawa, Masaru, Shigeyuki Uno, Noriyoshi Iriyama, et al.. (2018). Combined treatment with benzo[a]pyrene and 1α,25-dihydroxyvitamin D3 induces expression of plasminogen activator inhibitor 1 in monocyte/macrophage-derived cells. Toxicology and Applied Pharmacology. 345. 48–56. 2 indexed citations

Takeuchi, Jin, Shigeru Kusumoto, Hideki Akiyama, Yoshinobu Kanda, & Koji Izutsu. (2017). JSH guideline for tumors of hematopoietic and lymphoid tissues—leukemia: 3. Acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL). International Journal of Hematology. 106(6). 732–747. 4 indexed citations

Kumagai, Takashi, Eri Matsuki, Koiti Inokuchi, et al.. (2013). Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia. International Journal of Hematology. 99(1). 41–52. 19 indexed citations

Hatta, Yoshihiro, Y. Uchino, Hiromichi Takahashi, et al.. (2011). Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP. Experimental and Therapeutic Medicine. 3(2). 304–308. 6 indexed citations

Hatta, Yoshihiro, Jin Takeuchi, Kyoko Fujiwara, et al.. (2011). Analysis of Methylation Status of ZAR1, GATA4, CDH22, SOX3, SLC16A5, PFN2, EHD3 and TBPL1 in Hematological Malignancies. Blood. 118(21). 4631–4631. 1 indexed citations

Iriyama, Noriyoshi, Akira Horikoshi, Toshitake Tanaka, et al.. (2011). Successful treatment of Hodgkin lymphoma in second trimester of pregnancy: feasibility of ABVD regimen. International Journal of Hematology. 94(1). 104–107. 9 indexed citations

Miura, Katsuhiro, Yoshihiro Hatta, Toshitake Tanaka, et al.. (2011). Charlson Comorbidity Index is an independent prognostic factor among elderly patients with diffuse large B-cell lymphoma. Journal of Cancer Research and Clinical Oncology. 137(7). 1079–1084. 48 indexed citations

Hirabayashi, Yukio, Yoshihiro Hatta, Jin Takeuchi, et al.. (2011). Novel three-dimensional long-term bone marrow culture system using polymer particles with grafted epoxy-polymer-chains supports the proliferation and differentiation of hematopoietic stem cells. Experimental Biology and Medicine. 236(11). 1342–1350. 15 indexed citations

Kurosawa, Saiko, Takuhiro Yamaguchi, Shuichi Miyawaki, et al.. (2010). A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission. Blood. 117(7). 2113–2120. 41 indexed citations

10.

Kako, Shinichi, Satoshi Morita, Hisashi Sakamaki, et al.. (2010). A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor. Leukemia. 25(2). 259–265. 24 indexed citations

11.

Ohtake, Shigeki, Shuichi Miyawaki, Hitoshi Kiyoi, et al.. (2010). Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study. International Journal of Hematology. 91(2). 276–283. 19 indexed citations

12.

Nakagawa, Yoshiko, Katsuhiro Miura, Tetsuo Yamazaki, et al.. (2010). A case of treatment-related myelodysplastic syndrome spontaneously resolved by drug discontinuance. International Journal of Hematology. 91(3). 530–533. 1 indexed citations

13.

Kurosawa, Saiko, Takuhiro Yamaguchi, Naoyuki Uchida, et al.. (2009). Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy as Post-Remission Strategy in Elderly Patients with Non-M3 AML in CR1: Retrospective Analysis with 1036 Patients.. Blood. 114(22). 524–524. 2 indexed citations

14.

Takei, Masami, Hiroyuki Nakamura, Shigeyoshi Fujiwara, et al.. (2009). Epstein-Barr-Virus-Infected CD15 (Lewis X)-Positive Hodgkin-Lymphoma-Like B Cells in Patients with Rheumatoid Arthritis. The Open Rheumatology Journal. 3(1). 41–47. 2 indexed citations

15.

Sano, Makoto, Masahiko Sugitani, Takashi Ishige, et al.. (2007). Supplemental utility of nested PCR for the pathological diagnosis of disseminated trichosporonosis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 451(5). 929–935. 9 indexed citations

16.

Zembutsu, Hitoshi, Masamitsu Yanada, Asahi Hishida, et al.. (2007). Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy. International Journal of Oncology. 31(2). 313–22. 12 indexed citations

17.

Hatta, Yoshihiro, Tetsuo Yamazaki, Jin Takeuchi, et al.. (2006). Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells. International Journal of Oncology. 29(2). 437–43. 36 indexed citations

18.

Yanada, Masamitsu, Jin Takeuchi, Isamu Sugiura, et al.. (2005). High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group. Journal of Clinical Oncology. 24(3). 460–466. 335 indexed citations

19.

Yoshida, Minoru, Nobu Akiyama, Masatomo Takahashi, et al.. (2003). Management of infectious complications in patients with acute leukemia during chemotherapy : A questionnaire analysis by the Japan Adult Leukemia Study Group. 51(11). 703–710. 3 indexed citations

20.

Ochi, Hisako, Jin Takeuchi, & Avery A. Sandberg. (1985). Multiple cancers in a Turner's syndrome with 45,X/46,XXp - /46,XX/47,XXX karyotype. Cancer Genetics and Cytogenetics. 16(4). 335–339. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact